Your healthcare provider can explain the pros and cons of each option and recommend one that fits your budget
Meaningful but lower than injectable dual agonists
While some researchers indicate the keto diet might help individuals with type 2 diabetes, the American Diabetes Association (ADA) does not recommend one diet over another
Bloomberg reported that Aspen sees GLP1s as a durable long-term growth driver and that Stephen Saad expects semaglutide generics to attract 12 to 15 manufacturers, with intensifying price competition
Cagrilintide also has one of the lowest GI odds ratios among the incretin and amylin compound class in a 2025 Bayesian network meta-analysis of multi-target obesity therapies the relevance for the stack is that adding cagrilintide to retatrutide may not compound GI burden as severely as adding a second GLP-1 agonist would
Zepbound is the first and only approved treatment activating two incretin hormone receptors, GIP and GLP-1, to tackle an underlying cause of excess weight, according to Lillys announcement